View More
Gain expert insight into the emerging role of NRG1 fusions as rare oncogenic drivers in a variety of solid tumors and learn about the targeted therapies in development from expert commentaries, a text-based module, and a downloadable slideset.
Learn how experts detect and treat NRG1 fusion–positive solid tumors in this interactive text module with expert perspectives from Stephen V. Liu, MD, and Ryma Benayed, PhD, on applying emerging research to biomarker testing and treatment strategies for patients with NRG1 fusion–driven cancers.
Ryma Benayed, PhD
Stephen Liu, MD
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Released: February 2, 2022
Expired:
No longer available for credit
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.